{"id":230346,"date":"2017-07-26T14:49:53","date_gmt":"2017-07-26T18:49:53","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/florida-medical-cannabis-provider-liberty-health-sciences-begins-trading-today-new-cannabis-ventures-blog.php"},"modified":"2017-07-26T14:49:53","modified_gmt":"2017-07-26T18:49:53","slug":"florida-medical-cannabis-provider-liberty-health-sciences-begins-trading-today-new-cannabis-ventures-blog","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/liberty\/florida-medical-cannabis-provider-liberty-health-sciences-begins-trading-today-new-cannabis-ventures-blog.php","title":{"rendered":"Florida Medical Cannabis Provider Liberty Health Sciences Begins Trading Today &#8211; New Cannabis Ventures (blog)"},"content":{"rendered":"<p><p>Liberty    Health Sciences Commences Trading on the CSE Following Closing    of Business Combination    <\/p>\n<p>    TORONTO, ONTARIO(Marketwired  July 26, 2017)   <\/p>\n<p>    Liberty Health    Sciences Inc. (formerly SecureCom Mobile Inc.) (CSE: LHS)    (OTC: SCQBF)(Liberty or the Company) is pleased to announce    that, following the closing of the business combination (the    Transaction) previously announced on July 21, 2017, the    Corporations common shares commenced trading on the Canadian    Securities Exchange (the CSE) under the trading symbol LHS    at the opening of markets on July 26, 2017.  <\/p>\n<p>    As part of the Transaction, SecureCom Mobile Inc. changed its    name to Liberty Health Sciences Inc. and consolidated its    shares on a three (3) to one (1) basis.  <\/p>\n<p>    Liberty was launched to acquire and operate U.S.-based    companies in the medical cannabis market, with initial focus of    operations in the State of Florida where it entered into an    exclusive Management Agreement with Chestnut Hill Tree Farm,    LLC (Chestnut) which grants the company all economic risk and    rewards associated with the Florida-based operation. Liberty    intends to continue to target, for expansion, key U.S. states    that have approved medical use of marijuana and meets its    stringent investment criteria. Liberty takes a science-based,    data driven approach to continuous improvement and holds itself    to the highest standards when it comes to the cultivation and    production of medical cannabis.  <\/p>\n<p>    As a result of the closing of the Transaction, the directors    and executive officers of the Company are now:  <\/p>\n<p>    Further details about the Transaction and the Company as the    resulting issuer from the Transaction are available in the    filing statement of SecureCom Mobile Inc. dated June 19, 2017    filed in respect of the Transaction which has been filed under    SecureCom Mobiles profile on SEDAR at <a href=\"http:\/\/www.sedar.com\" rel=\"nofollow\">http:\/\/www.sedar.com<\/a>. The    summary of the Transaction set out herein is qualified in its    entirety by reference to the description of the Transaction in    the filing statement.  <\/p>\n<p>    For more information about Liberty please visit <a href=\"http:\/\/www.libertyhealthsciences.com\" rel=\"nofollow\">http:\/\/www.libertyhealthsciences.com<\/a>.  <\/p>\n<p>    About Liberty Health Sciences Inc.  <\/p>\n<p>    Liberty Health Sciences Inc. (Liberty) is an investor and    operator in the medical cannabis market, capitalizing on new    and existing opportunities in the United States. Libertys    stringent investment criteria for expansion maximizes returns    to shareholders, while focusing on significant near and    mid-term opportunities. Liberty has an extensive background in    highly regulated industries, with expertise in becoming a    low-cost producer. Liberty leverages commercial greenhouse    knowledge to deliver high-quality, clean and safe    pharmaceutical grade cannabis to patients.  <\/p>\n<p>    Original press release:<a href=\"http:\/\/www.marketwired.com\/press-release\/liberty-health-sciences-commences-trading-on-cse-following-closing-business-combination-cse-lhs-2227642.htm\" rel=\"nofollow\">http:\/\/www.marketwired.com\/press-release\/liberty-health-sciences-commences-trading-on-cse-following-closing-business-combination-cse-lhs-2227642.htm<\/a>  <\/p>\n<p>      Before this cannabis stock news is here, it's published to      subscribers on 420 Investor.    <\/p>\n<p>      The      NCV Newswire by New Cannabis Ventures aims to curate high      quality content and information about leading cannabis      companies to help our readers filter out the noise and to      stay on top of the most important cannabis business news. The      NCV Newswire is hand-curated by an editor and not automated      in anyway. For questions contact us.    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Original post: <\/p>\n<p><a target=\"_blank\" href=\"https:\/\/www.newcannabisventures.com\/florida-medical-cannabis-provider-liberty-health-sciences-begins-trading-today\/\" title=\"Florida Medical Cannabis Provider Liberty Health Sciences Begins Trading Today - New Cannabis Ventures (blog)\">Florida Medical Cannabis Provider Liberty Health Sciences Begins Trading Today - New Cannabis Ventures (blog)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Liberty Health Sciences Commences Trading on the CSE Following Closing of Business Combination TORONTO, ONTARIO(Marketwired July 26, 2017) Liberty Health Sciences Inc. (formerly SecureCom Mobile Inc.) (CSE: LHS) (OTC: SCQBF)(Liberty or the Company) is pleased to announce that, following the closing of the business combination (the Transaction) previously announced on July 21, 2017, the Corporations common shares commenced trading on the Canadian Securities Exchange (the CSE) under the trading symbol LHS at the opening of markets on July 26, 2017.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/liberty\/florida-medical-cannabis-provider-liberty-health-sciences-begins-trading-today-new-cannabis-ventures-blog.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[29],"tags":[],"class_list":["post-230346","post","type-post","status-publish","format-standard","hentry","category-liberty"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/230346"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=230346"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/230346\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=230346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=230346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=230346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}